Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder

Neurochemical Research

Volumn 29, Issue 12, 2004, Pages 2293-2302

  Chambers, Jessie S ^a   Perrone Bizzozero, Nora I ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

bipolar disorder; gender; hippocampus; immunocytochemistry; myelin; Schizophrenia

Indexed keywords

MYELIN BASIC PROTEIN;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BRAIN REGION; CELL POPULATION; CLINICAL ARTICLE; COGNITIVE DEFECT; COLON POLYPOSIS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDULLA OBLONGATA; MENTAL DISEASE; MYELINATION; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SCHIZOPHRENIA; SEX DIFFERENCE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; DENSITOMETRY; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYELIN BASIC PROTEINS; MYELIN SHEATH; PARAFFIN EMBEDDING; SCHIZOPHRENIA; SEX CHARACTERISTICS;

HIPPOCAMPUS HIPPOCAMPUS;

EID: 11144257049     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-004-7039-x     Document Type: Article

References (76)

1. Yakovlev, P. and LeCours, A. R. 1967. The myelinogenetic cycles of regional maturation of the brain. in Minkowski, A. (ed.), Regional development of the brain in early life, Oxford, England: Blackwell Scientific Publications.
2. Benes, F. M. 1989. Myelination of cortical-hippocampal relays during late adolescence. Schizophr. Bull. 15:585-593.
3. Benes, F. M., Turtle, M., Khan, Y., and Farol, P. 1994. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch. Gen. Psychiatry. 51:477-484.
4. Hyde, T. M., Ziegler, J. C., and Weinberger, D. R. 1992. Psychiatric disturbances in metachromatic leukodystrophy: Insights into the neurobiology of psychosis. Arch. Neurol. 49:401-406.
5. Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., and Fienberg, A. A. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98:4776-4751.
6. Copland, C. M., Dracheva, S., Davis, K. L., and Haroutunian, V. 2002. mRNA expression of three isoforms of myelin associated glycoprotein (MAG) in patients with schizophrenia. Society for Neuroscience Abstract.
7. Tkachev, D., Mimmack, M. L., Ryan, M. M., Wayland, M., Freeman, T., Jones, P. B., Starkey, M., Webster, M. J., Yolken, R. H., and Bahn, S. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798-805.
8. Cannon, T. D., van Erp, T. G. M., Huttunen, M., Lonnqvist, J., Salonen, O., Valanne, L., Poutanen, V., Standertskjold-Nordenstam, C. G., Gur, R. E., and Yan, M. 1998. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Am. J. Psychiatry. 55:1084-1091.
9. Wright, I., Rabe-Hesketh, S., Woodruff, P., David, A., Murray, R., and Bullmore, E. 2000. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry. 157:16-25.
10. Breier, A., Buchanan, R. W., Elkashef, A., Munson, R. C., Kirkpatrick, B., and Gellad, F. 1992. Brain morphology and schizophrenia: A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch. Gen. Psychiatry. 52:279-288.
11. Buchanan, R. W., Vladar, K., Barta, P. E., and Pearlson, G. D. 1998. Structural evaluation of the prefrontal cortex in schizophrenia. Am. J. Psychiatry. 155:1049-1055.
12. Sanfilipo, M., Lafargue, T., Rusinek, H., Arena, L., Loneragan, C., Lautin, A., Feiner, D., Rotrosen, J., and Wolkin, A. 2000. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: Relationship to negative symptoms. Arch. Gen. Psychiatry. 57:471-480.
13. Sigmundsson, T., Suckling, J., Maier, M., Williams, S., Bullmore, E., Greenwood, K., Pukuda, R., Ron, M., and Toone, B. 2001. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am. J. Psychiatry. 158:234-243.
14. Buchsbaum, M. S., Tang, C. Y., Peled, S., Gudbjartsson, H., Lu, D., Hazlett, E. A., Downhill, J., Haznedar, M., Fallon, J. H., and Atlas, S. W. 1998. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9:425-430.
15. Lim, K. O., Hedehus, M., Moseley, M., de Crespigny, A., Sullivan, E. V., and Pfefferbaum, A. 1999. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch. Gen. Psychiatry. 56:367-374.
16. Agartz, I., Andersson, J. L. R., and Skare, S. 2001. Abnormal brain white matter in schizophrenia: A diffusion tensor imaging study. Neuroreport 12:2251-2254.
17. Adler, C. M., Holland, S. K., Schmithorst, V., Wilke, M., Weiss, K. L., Pan, H., and Strakowski, S. M. 2004. Abnormal frontal white matter tracts in bipolar disorder: A diffusion tensor imaging study. Bipolar Disord. 6:197-203.
18. Orlovskaya, D. D., Vostrikov, V. M., Rachmanova, V. I., and Uranova, N. A. 2000. Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia, bipolar affective disorder, and major depression, (abstract). Schizophr. Res. 41:105-106.
19. Hof, P. R., Haroutunian, V., Coplan, C., Davis, K. L., and Buxbaum, J. D. 2002. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem. Res. 27:1193-1200.
20. Uranova, N. A., Orlovskaya, D. D., Vostrikov, V. M., and Rachmanova, V. I. 2002. Oligodendroglial reduction in the prefrontal cortex in schizophrenia. Euro. Psychiatry. 17(suppl):25-25.
21. Cotter, D., Mackay, D., Landau, S., Kerwin, R., and Everall, I. 2001. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry. 58:545-553.
22. Miyakawa, T., Sumiyoshi, S., Deshimaru, M., Suzuki, T., and Tomonari, H. 1972. Electron microscopic study on schizophrenia: Mechanism of pathological changes. Acta. Neuropathol. 20:67-77.
23. Uranova, N. A. and Orlovskaya, D. D. 1996. Ultrastructural pathology of neuronal connectivity in postmortem brain of schizophrenic patients. Ann. Psychiatry. 6:55-72.
24. Hamano, K., Iwasaki, N., Takeya, T., and Takita, H. 1996. A quantitative analysis of rat central nervous system myelination using the immunohistochemical method for MBP. Dev. Brain Res. 93:18-22.
25. Muse, E. D., Jurevics, H., Toews, A. D., Matsushima, G. K., and Morell, P. 2001. Parameters related to lipid metabolism as markers of myelination in mouse brain. J. Neurochem. 76:77-86.
26. Bhat, R. V., Axt, K. J., Fosnaugh, J. S., Smith, K. J., Johnson, K. A., Hill, D. E., Kinzler, K. W., and Baraban, J. M. 1996. Expression of the APC tumor suppressor protein in oligodendroglia. Gliav 17:169-174.
27. Hajra, K. M. and Fearon, E. R. 2002. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34:255-268.
28. Eastwood, S. L. and Harrison, P. J. 1995. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immautoradiography. Neuroscience 69:309-319.
29. Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., and Weickert, C. S. 2002. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry. 7:985-994.
30. Chambers, J. S., Thomas, D., Saland, L., Neve, R. L., and Perrone-Bizzozero, N. I. 2003. GAP-43 and synaptophysin immunostaining reveal subtle alterations in neural circuitry in the dentate gyrus of patients with schizophrenia. Schizophr. Res. 60(Suppl):69.
31. Hynd, M. R., Lewohl, J. M., Scott, H. L., and Dodd, P. R. 2003. Biochemical and molecular studies using human autopsy brain tissue. J. Neurochem. 85:543-562.
32. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Press.
33. Weinberger, D. R. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Biol. Pscychiatry. 45:395-402.
34. Andreasen, N. C., Rezai, K., Alliger, R., Swayze, V. W. II, Flaum, M., Kirchner, P., Cohen, G., and O'Leary, D. S. 1992. Hypofrontality in neuroleptic-naïve patients and in patients with choric schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch. Gen. Psychiatry. 49:943-958.
35. Lewis, D. A. 1997. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch. Gen. Psychiatry. 54:660-667.
36. Heckers, S., Rauch, S. L., Goff, D. C., Savage, C. R., Schacter, D. L., Fischman, A. J., and Alpert, N. M. 1998. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1:318-323.
37. Weinberger, D. R. 1999. Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry. 45:395-402.
38. Arnold, S. E. 2000. Cellular and molecular neuropathology of the parahippocampal region in schizophrenia. Ann. NY Acad. Sci. 911:275-292.
39. Benes, F. M. and Berretta, S. 2000. Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia. Ann. NY Acad. Sci. 911:293-304.
40. Harrison, P. J. and Eastwood, S. L. 2001. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11:508-519.
41. Lewis, D. A. and Levitt, P. 2002. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25:409-432.
42. Andreasen, N. C., Nopoulos, P., O'Leary, D. S., Miller, D. D., Wassink, T., and Flaum, M. 1999. Defining the phenotype of schizophrenia: Cognitive dysmetria and its neural mechanisms. Biol. Psychiatry. 46:908-920.
43. Benes, F. M. 2000. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 31:251-269.
44. Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., and Haroutunian, V. 2003. White matter changes in schizophrenia. Arch. Gen. Psychiatry. 60:443-456.
45. Steinmetz, H., Staiger, J. F., Schlaug, G., Huang, Y., and Jancke, L. 1995. Corpus callosum and brain volume in women and men. Neuroreport 6:1002-1004.
46. Tang, Y., Nyengaard, J. R., Pakkenberg, B., and Gundersen, H. J. 1997. Age-induced white matter changes in the human brain: A stereological investigation. Neurobiol. Aging. 18: 609-615.
47. Sloane, J. A., Hinman, J. D., Lubonia, M., Hollander, W., and Abraham, C. R. 2003. Age-dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpin-1 in the rhesus monkey. J. Neurochem. 84:157-168.
48. Muck-Seler, D., Pivac, N., Jakovljevic, M., and Brzovic, Z. 1999. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biol. Psychiatry. 45:1433-1439.
49. Walder, D. J., Walker, E. F., and Lewine, R. J. 2000. Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biol. Psychiatry. 48:1121-1132.
50. Gumbinas, M., Oda, M., and Huttenlocher, P. 1973. The effects of corticosteroids on myelination of the developing rat brain. Biol. Neonate. 22:355-366.
51. Bohn, M. and Friedrich, V. 1982. Recovery of myelination in rat optic nerve after developmental retardation by cortisol. J. Neurosci. 2:1292-1298.
52. Marcelis, M., Myin-Germeys, I., Suckling, J., Woodruff, P., Hofman, P., Bullmore, E., Delespaul, P., and van Os, J. 2003. Cerebral tissue alterations and daily life stress experience in psychosis. Acta. Psychiatr. Scand. 107:54-59.
53. Shors, T. J., Chadrick, C., and Falduto, J. 2001. Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. J. Neurosci. 21:6292-6297.
54. Luine, V. 2002. Sex differences in chronic stress effects on memory in rats. Stress 5:205-216.
55. Conrad, C. D., Grote, K. A., Hobbs, R. J., and Ferayorni, A. 2003. Sex differences in spatial and non-spatial Y-maze performance after chronic stress. Neurobiol. Learn. Mem. 79:32-40.
56. Valat, J., Privat, A., and Fulcrand, J. 1988. Experimental modifications of postnatal differentiation and fate of glial cells related to axo-glial relationships. Int. J. Dev. Neurosci. 6:245-260.
57. Kidd, G. J., Hauer, P. E., and Trapp, B. D. 1990. Axons modulate myelin protein messenger RNA levels during central nervous system myelination in vivo. J. Neurosci. Res. 26:409-418.
58. Barres, B. A. and Raff, M. C. 1993. Proliferation of oligodendrocyte precursor cells depends on electrical activity of axons. Nature 361:258-259.
59. Hardy, R. and Reynolds, R. 1993. Neuron-oligodendroglial interactions during central nervous system development. J. Neurosci. Res. 36:121-126.
60. Barres, B. A. and Raff, M. C. 1994. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 12:935-944.
61. Wang, S., Sdrulla, A. D., diSibio, G., Bush, G., Nofziger, D., Hicks, C., Weinmaster, G., and Barres, B. A. 1998. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21:63-75.
62. Mirsky, R., Winter, J., Abney, E. R., Pruss, R. M., Gavrilovic, J., and Raff, M. C. 1980. Myelin-specific proteins and glycolipids in rat Schwann cells and oligodendrocytes in culture. J. Cell. Biol. 84:483-494.
63. Lehman, D. M. and Harrison, J. M. 2002. Flash visual evoked potentials in the hypomyelinated mutant mouse shiverer. Doc. Opthalmol. 104:83-95.
64. Atkins, C. M., Chen, S. J., Klann, E., and Sweatt, J. D. 1997. Increased phosphorylation of myelin basic protein during hippocampal long-term potentiation. J. Neurochem. 68:1960-1967.
65. Cai, Z., Pang, Y., Xiao, F., and Rhodes, P. G. 2001. Chronic ischemia preferentially causes white matter injury in the neonatal rat brain. Brain Res. 898:126-135.
66. Gold, J. M., Rehkemper, G., Binks, S. W. III, Carpenter, C. J., Fleming, K., Goldberg, T. E., and Weinberger, D. R. 2000. Learning and forgetting in schizophrenia. J. Abnorm. Psychol. 109:534-538.
67. Kuperberg, G. and Heckers, S. 2000. Schizophrenia and cognitive function. Curr. Opin. Neurobiol. 10:205-210.
68. Marenco, S., Weinberger, D. R., and Schreurs, B. G. 2003. Single-cue delay and trace classical conditioning in schizophrenia. Biol. Psychiatry. 53:390-402.
69. Weiss, A. P., Schacter, D. L., Goff, D. C., Rauch, S. L., Alpert, N. M., Fischman, A. J., and Heckers, S. 2003. Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia. Biol. Psychiatry. 53:48-55.
70. Sweeney, J. A., Kmiec, J. A., and Kupfer, D. J. 2000. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol. Psychiatry. 48:674-685.
71. Deckersbach, T., Savage, C. R., Reilly-Harrington, N., Clark, L., Sachs, G., and Rauch, S. L. 2004. Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: The role of memory strategies. Bipolar Disord. 6:233-244.
72. Perlick, D., Mattis, S., Stanstny, P., and Teresi, J. 1992. Gender differences in cognition in schizophrenia. Schizophr. Res. 8:69-73.
73. Lewine, R. R., Walker, E. F., Shurett, F., Caudle, J., and Haden, C. 1996. Sex differences in neuropsychological functioning among schizophrenic patients. Am. J. Psychiatry. 153:1178-1184.
74. Goldstein, J. M., Seidman, K. J., Goodman, J. M., Koren, D., Lee, H., Weintraub, S., and Tsuang, M. T. 1998. Are there sex differences in neuropsychological functions among patients with schizophrenia? Am. J. Psychiatry. 155:1358-1364.
75. Hoff, A. L., Weineke, M., Faustman, W. O., Horon, R., Sakuma, M., Blankfeld, H., Espinoza, S., and DeLisi, L. E. 1998. Sex differences in neuropsychological functioning of first-episode and chronically ill schizophrenic patients. Am. J. Psychiatry. 155:1437-1439.
76. Weiser, M., Reichenberg, A., Rabinowitz, J., Kaplan, Z., Mark, M., Nahon, D., and Davidson, M. 2000. Gender differences in premorbid cognitive performance in a national cohort of schizophrenic patients. Schizophr. Res. 45:185-190.